These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 6094299)

  • 1. Effects of lysine-vasopressin (LVP) and 1-deamino-8-D-arginine-vasopressin (dDAVP) upon electrical potential, short-circuit current and transepithelial D.C. resistance of the frog skin.
    Bakos P; Ponec J; Lichardus B
    Gen Physiol Biophys; 1984 Aug; 3(4):297-305. PubMed ID: 6094299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of dDAVP and AVP on the sodium transport in the frog skin.
    Bakos P; Ponec J; Lichardus B
    Gen Physiol Biophys; 1990 Feb; 9(1):71-81. PubMed ID: 2311915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microelectrode study of insulin effect on apical and basolateral cell membrane of frog skin: comparison with the effect of 1-deamino-8-D-arginine-vasopressin (dDAVP).
    Ponec J; Bakos P; Lichardus B
    Gen Physiol Biophys; 1989 Jun; 8(3):245-55. PubMed ID: 2670663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of antidiuretic hormone analogues on intact and nystatin-permeabilized frog skins.
    Jared SR; Rao JP; Subramani S
    Exp Physiol; 2009 Dec; 94(12):1174-84. PubMed ID: 19666695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of the sodium transport across the frog skin by three N-terminally extended arginine-vasopressins.
    Ponec J; Bakos P; Lichardus B; Alexandrová M; Lammek B; Rekowski P; Kupryszewski G
    Gen Physiol Biophys; 1990 Aug; 9(4):403-9. PubMed ID: 2272488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of salmon melanin concentrating hormone on vasopressin analogue (dDAVP) activity and sodium transport in frog skin.
    Smriga M; Bakos P; Jezová D
    Gen Physiol Biophys; 1994 Oct; 13(5):413-24. PubMed ID: 7797049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of natriferic activity of the vasopressin molecule by modifications in positions 1, 2 and 4.
    Bakos P; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
    Gen Physiol Biophys; 1990 Dec; 9(6):605-13. PubMed ID: 2079200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opposite actions of different doses of arginine-vasotocin and 1-deamino-arginine-vasotocin on sodium ion transport in skin of the frog Rana temporaria].
    Bogolepova AE
    Zh Evol Biokhim Fiziol; 2011; 47(1):49-53. PubMed ID: 21469341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine-vasopressin and lysine-vasopressin have different effects on spontaneous behaviour of rats.
    Tendis S; Klingberg F; Schaeker W
    Biomed Biochim Acta; 1987; 46(10):719-25. PubMed ID: 3446200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Mercurascan on sodium transport in frog skin and bladder.
    Bures L; Heller J; Janácek K; Rybová R; Kleinová M; Kolc J; Málek P
    Physiol Bohemoslov; 1980; 29(6):569-75. PubMed ID: 6451885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-deamino-/4-valine-8-D-arginine/-vasopressin (dVDAVP), a new synthetic vasopressin analog for treating diabetes insipidus.
    László FA; Czakó L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):39-43. PubMed ID: 7056603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroosmotic activities of arginine-vasopressins modified either in positions 1, 2 and 4 or at N-terminal extensions.
    Bakos P; Shakhmatova EI; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
    Gen Physiol Biophys; 1992 Aug; 11(4):359-76. PubMed ID: 1426981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.
    Matsui K; Kimura T; Ota K; Iitake K; Shoji M; Inoue M; Yoshinaga K
    Endocrinol Jpn; 1985 Aug; 32(4):547-57. PubMed ID: 3936702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of a single dose of vasopressin analogs on human renal potassium excretion.
    Nádvorníková H; Schück O
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):155-8. PubMed ID: 7076344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients.
    Laczi F; Valkusz Z; Lászlo FA; Wagner A; Járdánházy T; Szász A; Szilárd J; Telegdy G
    Psychoneuroendocrinology; 1982; 7(2-3):185-93. PubMed ID: 7178372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vasopressin on sodium transport across inner medullary collecting duct.
    Kudo LH; van Baak AA; Rocha AS
    Am J Physiol; 1990 May; 258(5 Pt 2):F1438-47. PubMed ID: 2159725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.